CTC launches collaboration with OptiCell Solutions

Cell and Gene Therapy (CGT) has the potential to revolutionize the future of healthcare, from advanced treatments with curative intent. Through our collaboration with OptiCell Solutions, CTC can offer comprehensive support for your project, from planning and managing regulatory challenges to the collection of blood cells in clinical research.

OptiCell Solutions contributes advanced apheresis solutions and specialist expertise to collect specific target cells that are central to the project. By optimizing the collection of blood cells and minimizing unwanted cell types, we lay the foundation for a high-quality and efficient final product tailored to your process.

Together, CTC and OptiCell Solutions offer a complete solution that includes expert knowledge and the technology required to succeed with your project.

OptiCell Solutions’ pressrelease is available here.